Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nuon Therapeutics Inc.

www.nuontherapeutics.com

Latest From Nuon Therapeutics Inc.

Tobira Therapeutics adds two to management team

Tobira Therapeutics has appointed Helen Jenkins senior vice-president of programme leadership, and Dr Sean Dalziel vice-president of pharmaceutical development. Ms Jenkins most recently served as a corporate officer at Nuon Therapeutics and Saegis Pharmaceuticals, responsible for development operations, strategic planning and portfolio management. Dr Dalziel was previously Onyx Pharmaceuticals' representative to the FDA on CMC sections for all pipeline programmes.

Recent Financings of Private Companies (10/2010)

Start-Up's monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation and reagent sectors.

Fibrotech to progress fibrosis drug after new funding

The Australian venture Fibrotech Therapeutics has received A$3 million ($2 million) in new funding which it says will enable its lead candidate to complete Phase I trials. The University of Melbourne spin-out is developing analogues of the mast cell stabiliser tranilast for use in chronic fibrotic disorders related to kidney disease, heart failure, pulmonary fibrosis and arthritis.

Metabolic Disorders Cardiovascular
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Immune Disorders
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Nuon Therapeutics Inc.
  • Senior Management
  • Lee M Rauch, Pres. & CEO
    Tito Serafini, PhD, CSO
    Paulette Dillon, CBO
  • Contact Info
  • Nuon Therapeutics Inc.
    Phone: (650) 645-1800
    2775 Campus Dr.
    Ste. 175
    San Mateo, CA 94403
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register